Orient Bio's Largest Shareholder to Acquire 3 Million Shares... "Enhancing Shareholder Value"
Orient, the largest shareholder of OrientBio, has begun purchasing shares on the open market to stabilize the stock price.
According to OrientBio on June 24, the company plans to acquire 3 million shares, which accounts for approximately 5% of the total shares. The acquisition period is scheduled to run for 30 days, starting from August 10.
This additional share acquisition by Orient aims to strengthen responsible management as the largest shareholder and to enhance shareholder value through stock price stabilization. Once the transaction is completed, the combined stake of Orient and its related parties will reach 40.7%.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
A company representative stated, "The largest shareholder, Orient, increasing its stake demonstrates both a recognition that the stock is significantly undervalued and a strong commitment to enhancing shareholder value. If stock price stabilization is needed in the future, the largest shareholder and related parties, who have ample financial resources, plan to acquire additional shares."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.